SALIX PHARMACEUTICALS LTD Deferred Tax Assets, Net of Valuation Allowance, Current
SALIX PHARMACEUTICALS LTD had Deferred Tax Assets, Net of Valuation Allowance, Current of $207.68 million as of 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxAssetsNetCurrent · last filed 2015-03-02
- 2014-12-31: Deferred Tax Assets, Net of Valuation Allowance, Current $207.68M.
- 2014-09-30: Deferred Tax Assets, Net of Valuation Allowance, Current $222.11M; Deferred Tax Assets, Net of Valuation Allowance, Current as first filed $223.01M.
- 2014-06-30: Deferred Tax Assets, Net of Valuation Allowance, Current $222.96M; Deferred Tax Assets, Net of Valuation Allowance, Current as first filed $223.86M.
- 2014-03-31: Deferred Tax Assets, Net of Valuation Allowance, Current $233.31M; Deferred Tax Assets, Net of Valuation Allowance, Current as first filed $234.22M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance, Current | Deferred Tax Assets, Net of Valuation Allowance, Current as first filed |
|---|---|---|
| 2014-12-31 | $207.68M 10-K · filed 2015-03-02 | |
| 2014-09-30 | $222.11M 10-Q/A · filed 2015-03-02 | $223.01M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $222.96M 10-Q/A · filed 2015-03-02 | $223.86M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $233.31M 10-Q/A · filed 2015-03-02 | $234.22M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $85.79M 10-K · filed 2015-03-02 | $86.69M 10-K · filed 2014-02-28 |
| 2013-09-30 | $57.05M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $57.05M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $57.05M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $57.05M 10-K · filed 2015-03-02 | |
| 2012-09-30 | $39.29M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $50.52M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $50.52M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $50.52M 10-K · filed 2013-03-01 |